glp-1 news october 9 2025 Looming drug patent expirations draw generics firms GLP-1 Receptor Agonists and vision
Description
New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.
This product is a compounded preparation and has not been approved by the FDA
Supplied in a 5mg lyophilized vial for laboratory research only
In DIO mice treated with Semaglutide, weight loss attenuated, and body weight was maintained at a constant level after 2 weeks
